nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—P-Glycoprotein Inhibitors—Cyclosporine—focal segmental glomerulosclerosis	0.768	1	CiPCiCtD
Telaprevir—ALB—focal segmental glomerulosclerosis	0.184	1	CbGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.00303	0.0648	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—ACE—focal segmental glomerulosclerosis	0.00272	0.058	CbGpPWpGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.00259	0.0553	CbGpPWpGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.00233	0.0498	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—AGT—focal segmental glomerulosclerosis	0.00172	0.0368	CbGpPWpGaD
Telaprevir—CTSK—Osteoclast Signaling—SPP1—focal segmental glomerulosclerosis	0.0017	0.0363	CbGpPWpGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.00164	0.035	CbGpPWpGaD
Telaprevir—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.00163	0.0348	CbGpPWpGaD
Telaprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—COL4A4—focal segmental glomerulosclerosis	0.0016	0.0342	CbGpPWpGaD
Telaprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—COL4A1—focal segmental glomerulosclerosis	0.00147	0.0315	CbGpPWpGaD
Telaprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—COL4A3—focal segmental glomerulosclerosis	0.00124	0.0266	CbGpPWpGaD
Telaprevir—CTSS—Collagen formation—COL4A4—focal segmental glomerulosclerosis	0.00109	0.0233	CbGpPWpGaD
Telaprevir—CTSS—Collagen formation—COL4A1—focal segmental glomerulosclerosis	0.001	0.0214	CbGpPWpGaD
Telaprevir—CTSS—Collagen formation—COL4A3—focal segmental glomerulosclerosis	0.000848	0.0181	CbGpPWpGaD
Telaprevir—CMA1—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000796	0.017	CbGpPWpGaD
Telaprevir—CMA1—Activation of Matrix Metalloproteinases—MMP2—focal segmental glomerulosclerosis	0.000775	0.0166	CbGpPWpGaD
Telaprevir—CMA1—Peptide hormone metabolism—ACE—focal segmental glomerulosclerosis	0.000714	0.0153	CbGpPWpGaD
Telaprevir—CTSK—Activation of Matrix Metalloproteinases—MMP2—focal segmental glomerulosclerosis	0.000691	0.0148	CbGpPWpGaD
Telaprevir—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.00065	0.0139	CbGpPWpGaD
Telaprevir—CTSK—Collagen degradation—MMP2—focal segmental glomerulosclerosis	0.000602	0.0129	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.000595	0.0127	CbGpPWpGaD
Telaprevir—CMA1—Activation of Matrix Metalloproteinases—MMP9—focal segmental glomerulosclerosis	0.000582	0.0124	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000547	0.0117	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.00053	0.0113	CbGpPWpGaD
Telaprevir—CTSK—Activation of Matrix Metalloproteinases—MMP9—focal segmental glomerulosclerosis	0.000519	0.0111	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000487	0.0104	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.000483	0.0103	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000462	0.00987	CbGpPWpGaD
Telaprevir—CMA1—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.000453	0.00967	CbGpPWpGaD
Telaprevir—CTSK—Collagen degradation—MMP9—focal segmental glomerulosclerosis	0.000452	0.00967	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.000437	0.00933	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.00043	0.0092	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000412	0.0088	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000401	0.00858	CbGpPWpGaD
Telaprevir—CTSS—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.000354	0.00757	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000342	0.0073	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000339	0.00725	CbGpPWpGaD
Telaprevir—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000335	0.00716	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000305	0.00651	CbGpPWpGaD
Telaprevir—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.000295	0.625	CbGbCtD
Telaprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—focal segmental glomerulosclerosis	0.00029	0.00619	CbGpPWpGaD
Telaprevir—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000275	0.00588	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000257	0.00549	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000254	0.00543	CbGpPWpGaD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000251	0.00536	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000242	0.00517	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000229	0.00489	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.00021	0.00449	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000202	0.00432	CbGpPWpGaD
Telaprevir—CTSS—Collagen formation—MMP9—focal segmental glomerulosclerosis	0.000197	0.00422	CbGpPWpGaD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000189	0.00403	CbGpPWpGaD
Telaprevir—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000183	0.00391	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.00018	0.00385	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000178	0.0038	CbGpPWpGaD
Telaprevir—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.375	CbGbCtD
Telaprevir—CTSS—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000173	0.0037	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000169	0.00361	CbGpPWpGaD
Telaprevir—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000168	0.00359	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000165	0.00353	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000151	0.00322	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000149	0.00317	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000143	0.00306	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.000141	0.003	CbGpPWpGaD
Telaprevir—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.000139	0.114	CcSEcCtD
Telaprevir—CTSS—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000136	0.00291	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000135	0.00288	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000128	0.00273	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.000125	0.00268	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000124	0.00265	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MYH9—focal segmental glomerulosclerosis	0.000122	0.00262	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000122	0.00261	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00012	0.00256	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000113	0.00241	CbGpPWpGaD
Telaprevir—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000112	0.00239	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00011	0.00235	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	0.000108	0.0023	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000105	0.00225	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.000103	0.0022	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MYH9—focal segmental glomerulosclerosis	0.000101	0.00215	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000101	0.00215	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	9.97e-05	0.00213	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	9.59e-05	0.00205	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	9.33e-05	0.00199	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	9.31e-05	0.00199	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	8.87e-05	0.0019	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	8.54e-05	0.00183	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	8.25e-05	0.00176	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	8.21e-05	0.00175	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	8.08e-05	0.00173	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	7.91e-05	0.00169	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	7.9e-05	0.00169	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD79A—focal segmental glomerulosclerosis	7.42e-05	0.00158	CbGpPWpGaD
Telaprevir—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	7.33e-05	0.0603	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	7.28e-05	0.0599	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	7.23e-05	0.00154	CbGpPWpGaD
Telaprevir—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	7.13e-05	0.0587	CcSEcCtD
Telaprevir—Gout—Cyclosporine—focal segmental glomerulosclerosis	7.09e-05	0.0583	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	6.91e-05	0.00148	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.84e-05	0.00146	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.81e-05	0.00145	CbGpPWpGaD
Telaprevir—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	6.74e-05	0.0554	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	6.7e-05	0.00143	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	6.51e-05	0.00139	CbGpPWpGaD
Telaprevir—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	6.32e-05	0.052	CcSEcCtD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	6.16e-05	0.00132	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	6.12e-05	0.00131	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD79A—focal segmental glomerulosclerosis	6.11e-05	0.0013	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	6.06e-05	0.0013	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD40LG—focal segmental glomerulosclerosis	6.05e-05	0.00129	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	5.88e-05	0.00126	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	5.81e-05	0.00124	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	5.77e-05	0.00123	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.72e-05	0.00122	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	5.41e-05	0.00116	CbGpPWpGaD
Telaprevir—Eczema—Cyclosporine—focal segmental glomerulosclerosis	5.35e-05	0.044	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.23e-05	0.00112	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	5.15e-05	0.0011	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	5.04e-05	0.00108	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD40LG—focal segmental glomerulosclerosis	4.98e-05	0.00106	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	4.8e-05	0.00103	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	4.67e-05	0.000999	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	4.52e-05	0.000966	CbGpPWpGaD
Telaprevir—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	4.5e-05	0.037	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.44e-05	0.000948	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.3e-05	0.00092	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.08e-05	0.000871	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	3.89e-05	0.000831	CbGpPWpGaD
Telaprevir—Infestation—Cyclosporine—focal segmental glomerulosclerosis	3.7e-05	0.0305	CcSEcCtD
Telaprevir—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	3.7e-05	0.0305	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.68e-05	0.000787	CbGpPWpGaD
Telaprevir—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	3.5e-05	0.0288	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.4e-05	0.000727	CbGpPWpGaD
Telaprevir—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	3.28e-05	0.027	CcSEcCtD
Telaprevir—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	3.26e-05	0.0268	CcSEcCtD
Telaprevir—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	3.18e-05	0.00068	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	3.11e-05	0.000665	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	3.03e-05	0.000648	CbGpPWpGaD
Telaprevir—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	2.89e-05	0.0238	CcSEcCtD
Telaprevir—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	2.83e-05	0.0233	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.83e-05	0.000605	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	2.82e-05	0.000602	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	2.79e-05	0.000596	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	2.69e-05	0.000574	CbGpPWpGaD
Telaprevir—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	2.67e-05	0.022	CcSEcCtD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.62e-05	0.000559	CbGpPWpGaD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	2.45e-05	0.0201	CcSEcCtD
Telaprevir—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.41e-05	0.000516	CbGpPWpGaD
Telaprevir—Infection—Cyclosporine—focal segmental glomerulosclerosis	2.35e-05	0.0193	CcSEcCtD
Telaprevir—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	2.33e-05	0.000498	CbGpPWpGaD
Telaprevir—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	2.32e-05	0.019	CcSEcCtD
Telaprevir—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	2.31e-05	0.019	CcSEcCtD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.3e-05	0.000492	CbGpPWpGaD
Telaprevir—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	2.29e-05	0.0189	CcSEcCtD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	2.24e-05	0.000478	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.17e-05	0.000463	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.11e-05	0.000452	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	2.04e-05	0.0168	CcSEcCtD
Telaprevir—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	2.04e-05	0.0167	CcSEcCtD
Telaprevir—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	1.88e-05	0.0154	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.79e-05	0.000382	CbGpPWpGaD
Telaprevir—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	1.69e-05	0.0139	CcSEcCtD
Telaprevir—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	1.67e-05	0.0137	CcSEcCtD
Telaprevir—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	1.62e-05	0.0133	CcSEcCtD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.6e-05	0.000341	CbGpPWpGaD
Telaprevir—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	1.56e-05	0.0128	CcSEcCtD
Telaprevir—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	1.5e-05	0.0123	CcSEcCtD
Telaprevir—Rash—Cyclosporine—focal segmental glomerulosclerosis	1.49e-05	0.0122	CcSEcCtD
Telaprevir—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	1.49e-05	0.0122	CcSEcCtD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.41e-05	0.000302	CbGpPWpGaD
Telaprevir—Nausea—Cyclosporine—focal segmental glomerulosclerosis	1.4e-05	0.0115	CcSEcCtD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.39e-05	0.000297	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	1.39e-05	0.000296	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.37e-05	0.000293	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.37e-05	0.000292	CbGpPWpGaD
Telaprevir—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	1.16e-05	0.000249	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.15e-05	0.000246	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	1.03e-05	0.000219	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.02e-05	0.000218	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.45e-06	0.000202	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	8.98e-06	0.000192	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.73e-06	0.000187	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.28e-06	0.000177	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	7.28e-06	0.000156	CbGpPWpGaD
Telaprevir—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	7.11e-06	0.000152	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	6.29e-06	0.000134	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	6.23e-06	0.000133	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	6.08e-06	0.00013	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	5.54e-06	0.000118	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	5.33e-06	0.000114	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.1e-06	0.000109	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	4.09e-06	8.74e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	3.84e-06	8.2e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	3.28e-06	7.01e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	2.52e-06	5.38e-05	CbGpPWpGaD
